BIOMAT Database Logo BIOMAT Database Logo

Diagnosis of activated protein C resistance (factor V Leiden) 1994

R Baker, and J Thom, and F van Bockxmeer

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

R Baker, and J Thom, and F van Bockxmeer
Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden.
July 2023, Seminars in thrombosis and hemostasis,
R Baker, and J Thom, and F van Bockxmeer
[Factor V Leiden and activated protein C resistance].
June 1997, Revue medicale de Bruxelles,
R Baker, and J Thom, and F van Bockxmeer
Factor V Leiden and activated protein C resistance.
January 2009, Advances in clinical chemistry,
R Baker, and J Thom, and F van Bockxmeer
Erratum: Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden.
October 2023, Seminars in thrombosis and hemostasis,
R Baker, and J Thom, and F van Bockxmeer
Activated protein C resistance testing for factor V Leiden.
December 2014, American journal of hematology,
R Baker, and J Thom, and F van Bockxmeer
Activated protein C resistance assay and factor V Leiden.
August 2014, The New England journal of medicine,
R Baker, and J Thom, and F van Bockxmeer
Resistance to activated protein C and factor V Leiden.
June 1997, QJM : monthly journal of the Association of Physicians,
R Baker, and J Thom, and F van Bockxmeer
Activated protein C resistance and factor V Leiden in Mexico.
October 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
R Baker, and J Thom, and F van Bockxmeer
[Activated protein C resistance and factor V Leiden: clinical interest].
October 2011, Pathologie-biologie,
R Baker, and J Thom, and F van Bockxmeer
Activated protein C resistance and factor V Leiden: a review.
June 2007, Archives of pathology & laboratory medicine,
Copied contents to your clipboard!